SCHEMBL9112690

SCHEMBL9112690

[CH2]C=C(C)c1c(OC)cc(OC)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.50
USP2 O75604 1/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ABCG2 Q9UNQ0 5/20 0.45
ERN1 O75460 1/20 0.42
KMT2A Q03164 2/20 0.41
NQO2 P16083 1/20 0.40
ABL1 P00519 1/20 0.39
BCR P11274 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
NFKB1 P19838 1/20 0.39
DPP4 P27487 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9112687 1.00 CYP3A4 (0.50) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL16617490 0.77 CYP3A4 (0.47) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL16617488 0.77 CYP3A4 (0.47) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL16617843 0.77 CYP3A4 (0.55) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL16389267 0.74 CYP3A4 (0.57) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL2029772 0.72 CYP3A4 (0.78) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL18793123 0.72 CYP3A4 (0.55) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL2096044 0.71 CYP3A4 (0.58) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL24737164 0.71 CYP3A4 (0.68) CYP3A4USP2MAPK1SMN1; SMN2ABCG2
SCHEMBL15155207 0.71 ABCG2 (0.60) CYP3A4USP2MAPK1SMN1; SMN2ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1114834-A antidiabetic agent OTSUKA PHARMA CO LTD (JP) 1996-01-10 CN disclosed
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed